documents

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

5 rows where docket_id = "FDA-2019-D-4751" sorted by posted_date descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: subtype, posted_date, posted_month, comment_start_date, open_for_comment, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)

posted_year 2

document_type 2

agency_id 1

id agency_id docket_id title document_type subtype posted_date ▲ posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2019-D-4751-0013 FDA None FDA-2019-D-4751 FDA Reauthorization Act Implementation Guidance for Pediatric Studies of Molecularly Targeted Oncology Drugs; Guidance for Industry; Availability Notice Notice of Availability 2021-05-25T04:00:00Z 2021 5 2021-05-25T04:00:00Z   2021-05-25T12:41:42Z 2021-11022 0 0 0900006484b333db
FDA-2019-D-4751-0014 FDA None FDA-2019-D-4751 FDARA Implementation Guidance for Pediatric Studies of Molecularly Targeted Oncology Drugs: Amendments to Sec. 505B of the FD&C Act; Guidance for Industry Other Guidance 2021-05-25T04:00:00Z 2021 5 2021-05-25T04:00:00Z   2024-11-06T23:47:24Z   1 0 0900006484b332a2
FDA-2019-D-4751-0003 FDA None FDA-2019-D-4751 Request for Extension from Biotechnology Innovation Organization (BIO) Other Request for Extension 2019-12-30T05:00:00Z 2019 12 2019-12-30T05:00:00Z   2019-12-30T20:17:17Z   0 0 090000648424d4c8
FDA-2019-D-4751-0002 FDA None FDA-2019-D-4751 FDARA Implementation Guidance for Pediatric Studies of Molecularly Targeted Oncology Drugs: Amendments to Sec. 505B of the FD&C Act Guidance for Industry Other Guidance 2019-12-13T05:00:00Z 2019 12 2019-12-13T05:00:00Z   2024-11-12T23:14:00Z   1 0 090000648420cd07
FDA-2019-D-4751-0001 FDA None FDA-2019-D-4751 Food and Drug Administration Reauthorization Act Implementation Guidance for Pediatric Studies of Molecularly Targeted Oncology Drugs; Draft Guidance for Industry; Availability Notice Notice of Availability 2019-12-13T05:00:00Z 2019 12 2019-12-13T05:00:00Z 2020-02-12T04:59:59Z 2020-05-06T20:45:01Z 2019-26877 0 0 090000648420c58d

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options: 

CREATE TABLE documents (
    id TEXT PRIMARY KEY,
    agency_id TEXT,
    docket_id TEXT REFERENCES dockets(id),
    title TEXT,
    document_type TEXT,
    subtype TEXT,
    posted_date TEXT,
    posted_year INTEGER,
    posted_month INTEGER,
    comment_start_date TEXT,
    comment_end_date TEXT,
    last_modified TEXT,
    fr_doc_num TEXT,
    open_for_comment INTEGER,
    withdrawn INTEGER,
    object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);
CREATE INDEX idx_docs_comment_end ON documents(comment_end_date) WHERE comment_end_date IS NOT NULL AND withdrawn = 0;